SGLT-2 inhibitors: pharmacokinetics characteristics and effects on lipids

Filippas-Ntekouan, S; Tsimihodimos, V; Filippatos, T; Dimitriou, T; Elisaf, M

Filippatos, T (reprint author), Univ Hosp Heraklion, Sch Med, Dept Internal Med, Iraklion 71500, Crete, Greece.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018; 14 (11): 1113

Abstract

Introduction: Type 2 diabetes mellitus is characterized by increased cardiovascular morbidity and mortality. Atherogenic dyslipidemia is common in thi......

Full Text Link